Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques

AAPS Journal

Volumn 5, Issue 2, 2003, Pages

  Gupta, Supriya ^a   Kaisheva, Elizabet ^a  

^a PROTEIN DESIGN LABS INC   (United States)

Author keywords

Experimental design; Monoclonal antibody; Multidose formulation; Preservative; Protein

Indexed keywords

EID: 55449120831     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. McGoff P, Scher DS. Solution formulation of proteins/peptides. In: McNally EJ, ed. Protein Formulation and Delivery. New York, NY: Marcel Dekker; 2000:139-158.
2. Akers MJ, Defelippis MR. Peptides and proteins as parenteral solutions. In: Frokjaer S, Hovgaard L, eds. Pharmaceutical Formulation Development of Peptides and Proteins. Philadelphia, PA: Taylor and Francis; 2000:145-177.
3. Bontempo JA. Formulation development. In: Bontempo JA, ed. Development of Biopharmaceutical Parenteral Dosage Forms. New York, NY: Marcel Dekker; 1997:109-142.
4. Lachman L, Weinstein S, Hopkins G, Slack S, Eisman P, Cooper J. Stability of antibacterial preservatives in parenteral solutions, I. Factors Influencing the Loss of Antimicrobial Agents from Solutions in Rubber-Stoppered Containers, J Pharm Sei. 1962;51(3):224-232.
5. Kakemi K, Sezaki H, Arakawa E, Ideda K. Interaction of parabens and other pharmaceutical adjuvants with plastic containers. J Chem Pharm Bull. 1971;19(12):2523-2529.
6. Akers MJ. Considerations in selecting antimicrobial preservatives for parenteral product development. Pharm Technol. 1984;8(5):36-44.
7. Beasley CRW, Rafferty P, Holgate ST. Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent) nebulizer solution. Br Med J. 1987;294:1197-1198.
8. Maa YF, Hsu CC. Aggregation of recombinant human growth hormone induced by phenolic compounds. Int J Pharm. 1996;140:155-168.
9. Kim Y, Rose CA, Liu Y, Ozaki Y, Datta G, Ut AT. FT-IR and near-infrared FT-Raman studies of the secondary structure of insulinotropin in the solid state: α-helix to β-sheet conversion by phenol and/or high shear force. J Pharm Sei. 1994;83:1175-1180.
10. Lam XM, Patapoff TW, Nguyen TH. The effect of benzyl alcohol on recombinant human interferon-y. Pharm Res. 1997;14:725-729.